CORONA Pandemic – How World is Responding to it


An inner quest that most people have in their mind & afraid of the solution but yet want to learn about it. It’s documented that Corona pandemic cases in countries till 17th June was

Russia's Ministry of Health names three drugs that can treat new Chinese coronavirus

By Jonny Tickle, RT

While experts across the world search for a vaccine to tackle the dangerous new infection, Russian health bosses have identified a trio of existing medicines to combat 2019-nCoV in adults. The new coronavirus can be fought with ribavirin, lopinavir/ritonavir and interferon beta-1b, they believe. These drugs are typically used to treat hepatitis C, HIV and multiple sclerosis respectively.

AbbVie's HIV Drug Aluvia Seen as Potential Treatment for Coronavirus

More than 80 people have died from the coronavirus in China. The Chinese government is turning to a drug developed by AbbVie for HIV patients as a potential treatment for the outbreak that has reached the shores of the United States.

AbbVie said it was donating more than one million dollars' worth of Aluvia, a combination of lopinavir and ritonavir as an ad-hoc treatment for pneumonia that is associated with the outbreak. The Chinese government suggested last week that taking two lopinavir/ritonavir pills and inhaling a dose of nebulized alpha-interferon twice a day could benefit these patients, Reuters reported. There are more than 2,000 known cases of the coronavirus in China. The illness has caused parts of China to grind to a halt as health officials seek to contain the spread of the virus.

China Testing HIV Drug as Treatment for New Coronavirus, AbbVie Says

(Reuters) - China is testing an HIV drug as a treatment for symptoms of the new coronavirus that is rapidly spreading, said drugmaker AbbVie Inc on Sunday.

China health authorities requested the drug to help with the government's efforts to address the crisis, according to Adelle Infante, a spokeswoman for North Chicago, Illinois-based AbbVie.

Aluvia, which is also known as Kaletra, is a combination of lopinavir and ritonavir.

China repurposes AbbVie HIV drug as Big Pharma rallies to combat deadly coronavirus

To battle the coronavirus emergency, Chinese government and medical experts are taking some unconventional measures, including publicly backing off-label use of a Big Pharma drug.

AbbVie's fixed-dose HIV drug Kaletra—also known as Aluvia, is now recommended as a treatment for pneumonia caused by the new coronavirus known as 2019-nCoV, China's National Health Commission says in its updated clinical guidance.

In response, the Illinois pharma is donating CNY 10 million (about $1.5 million) worth of the drug to help contain the virus, its China branch said (Chinese) Friday.

AbbVie donates $1M+ of the HIV drug that China is now recommending for coronavirus treatment

AbbVie is donating more than $1 million worth of an HIV drug to help combat the fast-spreading coronavirus outbreak in China, the company announced on Friday.

China's National Health Commission has suggested Aluvia, a pill containing lopinavir and ritonavir, as one of two possible treatments for the symptoms of the virus currently known as 2019-nCoV in the absence of effective antiviral medications. The other part is nebulized alpha-interferon.

A crop of drugmakers — now including J&J — is racing to add more potential weapons to the arsenal.

Can an anti-HIV combination or other existing drugs outwit the new coronavirus?

When a frightening new virus emerges in humans, scientists spend many months, if not years, developing and testing a vaccine. Finding new treatments, too, takes a long time, but there is another option: Try existing drugs to see whether they have activity against the new virus.

In the case of the novel coronavirus (2019-nCoV), researchers are already trying antivirals widely used to treat HIV, in hopes they might be able to fight the coronavirus as well. Other, still experimental antivirals—including one that was unsuccessfully tested against Ebola last year—may also hold promise.

This information is collected from online sources and presented in public interest by
Viewers are required to consult their Prescribing Physician before taking any treatment decision.